Retina

Inherited retinal diseases have disease processes distinct from age-related macular degeneration and geographic atrophy, but may present with "phenocopy" clinical signs

Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden

Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

In a keynote speech, Warren Hoburg and Tyson J. Brunstetter, OD, PhD, will discuss in-orbit imaging and spaceflight-associated neuro-ocular syndrome

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom

The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke

The researchers reported a “notable” correlation which could serve as a predictive biomarker

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

The authors evaluated shallow irregular pigment epithelial detachment, subretinal hyperreflective material, subretinal fluid, intraretinal fluid and other baseline OCT biomarkers

Researchers screened for outcomes such as the presence of retinal diseases including age-related macular degeneration and retinal vein occlusion

The implant was tested in eyes of patients with bilateral age-related macular degeneration who underwent cataract surgery

Choroidal and retinal changes were examined with optical coherence tomography angiography

Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States

OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication